33.80SEK-1.46%Mkt Cap: 1.11B SEKP/E: 38.41Last update: 2026-06-01
C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company off…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap1.11B SEK
Enterprise Value1.04B SEK
Revenue (TTM)427.80M SEK
Gross Profit316.05M SEK
Net Income (TTM)10.46M SEK
Revenue/Share12.65 SEK
Last Price33.80 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees110
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)38.41
P/E (Forward)15.18
PEG—
EV/EBITDA16.83
EV/Revenue2.43
P/S2.64
P/B3.34
EPS (TTM)0.88
EPS (Forward)2.26
52W Range
24.6072% of range37.40
52W High37.40 SEK
52W Low24.60 SEK
Profitability
Gross Margin71.52%
Oper. Margin11.46%
EBITDA Margin14.42%
Profit Margin2.37%
ROE3.01%
ROA2.09%
Growth
Revenue Growth-11.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF71.08M SEK
CapEx (TTM)20.78M SEK
FCF Margin-0.83%
FCF Yield-0.32%
Net Debt-125.80M SEK
Net Debt/EBITDA-2.04
Balance Sheet
Debt/Equity0.03
Current Ratio3.10
Quick Ratio2.41
Book Value/Sh10.26 SEK
Cash/Share3.984 SEK
Dividends
Fwd Div Rate0.1000 SEK
Trail. Div Rate0.1000 SEK
Div. Yield0.29%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateMay 8, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)36.00 SEK
Target Range36.00 SEK – 36.00 SEK
# Analysts1
Ownership
Shares Out.32.12M
Float22.15M
Insiders50.36%
Institutions26.99%
Technical
SMA 5029.09 (+16.2%)
SMA 20030.75 (+9.9%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)29.45K
Avg Vol (10d)19.47K
Technical Indicators
RSI (14)63.7
MACD1.7158
MACD Signal1.8919
MACD Hist.-0.1761
BB Upper39.74 SEK
BB Middle32.97 SEK
BB Lower26.20 SEK
BB Width41.08%
ATR (14)1.285 SEK
Vol Ratio (20d)0.43x